The goal of IVEG is to foster the development and dissemination of evidence-based guidelines to improve animal health and welfare benefiting animals, humans and planetary health.
ENOVAT
The COST Action ENOVAT was initiated by representatives from the EUCAST Veterinary Subcommittee (VetCAST) and the ESCMID Study Group for Veterinary Microbiology (ESGVM) to tackle key challenges in veterinary antimicrobial use across Europe. From 2019 to May 2024, ENOVAT united 332 specialists from 51 countries, creating a collaborative network dedicated to improving veterinary antimicrobial therapy.
One of the primary aims of ENOVAT was to develop evidence-based, animal- and disease-specific antimicrobial treatment guidelines to support effective and responsible prescribing, maximizing the health and welfare of animals while combatting antimicrobial resistance. To achieve this, ENOVAT established guideline drafting groups for six priority conditions in 2020. The processes, outcomes, and capacity-building efforts are summarized in our White Paper, with a focus on sustainability.
The ENOVAT guidelines in companion animals are endorsed and disseminated by the World Small Animal Veterinary Association (WSAVA).
Explore our White Paper https://doi.org/10.12688/openreseurope.18016.2
From 2026, the ENOVAT guidelines are hosted by the IVEG centre at the UCPH.